When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RARE - Ultragenyx appoints Eric Crombez Chief Medical Officer and executive Vice President
Ultragenyx Pharmaceutical Inc.
2023-03-14 08:51:59 ET
Ultragenyx Pharmaceutical ( NASDAQ: RARE ) promotes Eric Crombez to Chief Medical Officer and executive Vice President succeeding Camille Bedrosian, effective May 1, 2023
Camille Bedrosian will remain with the company in a full-time strategic advisory role.
Dr. Crombez joined the company following the acquisition of Dimension Therapeutics in November 2017and currently serves as Chief Medical Officer for gene therapy and inborn errors of metabolism.